Skip to content

QUICKREAD SYSTEM: QUICKREAD CRP KIT - Quickread 101 Instrument, Model 06088

by Orion Diagnostica, OY

510(k) K042442

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK042442 Date24 Sep 2004ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DCK
Models / Variants
Quickread 101 Instrument, Model 06088
Device Class
Class II
Regulation
21 CFR Part 866.5270
Advisory Committee
Immunology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The QuickRead System is a diagnostic device for the quantitative measurement of C-reactive protein (CRP) in whole blood or plasma. CRP is an acute-phase protein used as a biomarker to assess inflammatory responses, aiding in the evaluation of infectious or non-infectious inflammatory conditions.

The system consists of a CRP Kit (Model 06085), a QuickRead 101 Instrument (Model 06088), and a CRP Control Set. It is intended for single-use in clinical laboratory settings and has received FDA 510(k) clearance under Special Review (SESE) in the Immunology category. The device is classified as Class II and regulated under 21 CFR 866.5270.

Other devices from Orion Diagnostica, Inc.

See all devices from Orion Diagnostica, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What clinical conditions can the QuickRead CRP Kit help evaluate using C-reactive protein levels as a biomarker?

    The QuickRead System measures C-reactive protein (CRP) in whole blood or plasma to assess inflammatory responses. CRP is used as a biomarker to evaluate both infectious and non-infectious inflammatory conditions, such as infections, autoimmune diseases, or other systemic inflammatory processes. It aids clinicians in monitoring disease activity or response to treatment in conditions where inflammation plays a key role.

  • Is the QuickRead CRP Kit designed for single-use or repeated use in a clinical setting?

    The QuickRead CRP Kit (Model 06085) is explicitly intended for single-use in clinical laboratory settings. This design ensures patient safety and consistency in test results, as reuse could compromise sterility or accuracy. The accompanying QuickRead 101 Instrument (Model 06088) is also intended for use with single-use kits.

  • How is the QuickRead System supplied, and what components are included in the full kit?

    The QuickRead System consists of three main components: the QuickRead CRP Kit (Model 06085), the QuickRead 101 Instrument (Model 06088), and the QuickRead CRP Control Set. These components work together to perform quantitative CRP measurements in whole blood or plasma. The kit is designed for use in clinical laboratories, where the instrument reads results from the single-use CRP test strips included in the kit.

  • What regulatory pathway was followed for FDA clearance of the QuickRead System, and what category does it fall under?

    The QuickRead System received FDA 510(k) clearance under Special Review (SESE) in the Immunology category. This classification aligns with its use for measuring CRP, a key biomarker in inflammatory and immune-related evaluations. The device is classified as Class II and regulated under 21 CFR 866.5270, reflecting its role in diagnostic testing for clinical decision-making.